Sonoma Pharmaceuticals, Inc. Stock Analysis & AI Score
Sonoma Pharmaceuticals, Inc. (SNOA) has an ST Score of 46.7 (C+), driven by its Valuation (A-) and held back by its Momentum (D). Analysts rate it Buy.
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Sonoma Pharmaceuticals, Inc. (SNOA) has an ST Score of 46.7 (C+), driven by its Valuation (A-) and held back by its Momentum (D). Analysts rate it Buy.
- Strongest
- ValuationA-
- Weakest
- MomentumD
All factor grades
- ValuationA-
- Financial StrengthA-
- GrowthC+
- ProfitabilityD+
- MomentumD
- Piotroski4/9
Contact
SNOA stock: frequently asked questions
What is SNOA's ST Score?
Sonoma Pharmaceuticals, Inc. (SNOA) has an ST Score of 46.7 (C+), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is SNOA a buy, hold, or sell?
Analysts rate SNOA a Buy. Our ST Score grades it C+ (46.7/100). The ST Score is a data-driven signal, not a recommendation.
What are SNOA's factor grades?
Valuation A-, Profitability D+, Financial Strength A-, Momentum D, Growth C+.
What is SNOA's valuation grade?
Sonoma Pharmaceuticals, Inc. (SNOA) earns a valuation grade of A-, measured against Drug Manufacturers - Specialty & Generic peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is SNOA's growth grade?
Sonoma Pharmaceuticals, Inc. (SNOA) earns a growth grade of C+, measured against Drug Manufacturers - Specialty & Generic peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is SNOA's profitability grade?
Sonoma Pharmaceuticals, Inc. (SNOA) earns a profitability grade of D+, measured against Drug Manufacturers - Specialty & Generic peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is SNOA's financial strength grade?
Sonoma Pharmaceuticals, Inc. (SNOA) earns a financial strength grade of A-, measured against Drug Manufacturers - Specialty & Generic peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is SNOA's Piotroski score?
Sonoma Pharmaceuticals, Inc. (SNOA) has a Piotroski F-Score of 4 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.